NephroGenex, Inc. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/62880d32-503e-41ac-b459-f1118bf9b728/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-22.3M | 2015-01-01 – 2015-12-31 | evidence 0001338095-16-000103 |
| FY 2014 | $-16.6M | 2014-01-01 – 2014-12-31 | evidence 0001338095-15-000016 |
| FY 2013 | $-35.0M | 2004-05-25 – 2014-03-31 | evidence 0001104659-14-038337 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).